trump glp 1 The Administration is delivering big news in Medicare! Through the Medicare GLP-1 Bridge, eligible beneficiaries can access certain GLP-1 medications for weight management for just a $50 monthly copay. It's a The Great GLP-1 Reset: Trump's

Wegovy, another Novo Nordisk drug with semaglutide, is prescribed to help obese people lose weight and to reduce the risk of major cardiovascular events in obese or overweight adults with known heart disease

As MBS leaderand Accomplish Health advisorJOHN MORTON puts it: Combining surgical approaches and GLP-1 receptor agonist therapy presents an opportunity to further improve outcomes for patients undergoing MBS. --- Review: Combining Medications With Bariatric Surgery to Treat Obesity To view or add a comment, sign in Compared with GLP-1 RAs, bariatric metabolic surgery was associated with lower rates of: All-cause mortality Major adverse cardiovascular events (MACE) Nephropathy Retinopathy These findings indicate that even with the availability of GLP-1 RAs, metabolic surgery remains superior to medical treatment for macrovascular and microvascular outcomes in patients with diabetes and obesity

Preventive Services Task Force recommends that most people get a colorectal screening at least once every 10 years, now starting at age 45 years, to check for signs of colon cancer

Patients who have recently started taking a GLP-1 receptor agonist may be at greater risk of delayed gastric emptying than those who have been taking one of these medications for a longer period

For dosage information, we found that 58.4% of semaglutide users and 64.3% of tirzepatide users self-reported a dosage equal to that recorded in the EHR

Mojsov's lab notes from 1983 includes her handwritten notations marking the key cleavage site in the preproglucagon sequence she considered critical to releasing the biologically active form of the peptide, namely GLP-1 (7-37)